دورية أكاديمية

Effectiveness of alteplase infusion for the management of prosthetic mitral valve thrombosis in paediatric age group and proposed algorithm.

التفاصيل البيبلوغرافية
العنوان: Effectiveness of alteplase infusion for the management of prosthetic mitral valve thrombosis in paediatric age group and proposed algorithm.
المؤلفون: Mashali MH; Paediatric Cardiology Department, King Faisal Specialist Hospital and Research centre, Jeddah, Saudi Arabia.; Department of Paediatrics, Faculty of medicine, Cairo University, Cairo, Egypt., Ahmad Z; Paediatric Cardiology Department, King Faisal Specialist Hospital and Research centre, Jeddah, Saudi Arabia., Omar Galal M; Paediatric Cardiology Department, King Faisal Specialist Hospital and Research centre, Jeddah, Saudi Arabia., Al-Kouatli A; Paediatric Cardiology Department, King Faisal Specialist Hospital and Research centre, Jeddah, Saudi Arabia.
المصدر: Cardiology in the young [Cardiol Young] 2023 May; Vol. 33 (5), pp. 747-753. Date of Electronic Publication: 2022 Jun 03.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cambridge University Press Country of Publication: England NLM ID: 9200019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1467-1107 (Electronic) Linking ISSN: 10479511 NLM ISO Abbreviation: Cardiol Young Subsets: MEDLINE
أسماء مطبوعة: Publication: <2005->: Cambridge : Cambridge University Press
Original Publication: Chapel Hill, NC : World Publishers, c1991-
مواضيع طبية MeSH: Heart Valve Diseases*/complications , Thrombosis*/etiology , Heart Valve Prosthesis*/adverse effects, Humans ; Child ; Tissue Plasminogen Activator/therapeutic use ; Fibrinolytic Agents/therapeutic use ; Mitral Valve ; Retrospective Studies ; Thrombolytic Therapy ; Hemorrhage/complications ; Hemorrhage/drug therapy
مستخلص: Introduction: The incidence of prosthetic valve implantation is increasing in the paediatric population. Prosthetic valve thrombosis leading to obstruction could potentially be a life-threatening complication. There is a debate regarding optimal management of this complication, and there is limited use of thrombolytic therapy in childhood in the setting of valve thrombosis.
Objective: We aim to share our experience of successfully using fibrinolytic therapy in terms of alteplase for paediatric prosthetic mitral valve thrombosis and to propose a management algorithm.
Methods: This retrospective analysis of the database was conducted at our hospital including patients who underwent thrombolysis (alteplase) for prosthetic mitral valve thrombosis from June, 2011 to June, 2021. A total of 10 patients with 20 attempts of alteplase infusion were found in our record.
Results: Alteplase was successful in 19 attempts to relieve valve thrombosis. The safe and effective dose of alteplase was between 0.1 and 0.3 mg/kg/hour. There were no associated major bleeding complications and alteplase was administered either by central or peripheral line.
Conclusion: Thrombolysis by alteplase infusion was found to be successful in relief of prosthetic mitral valve thrombosis in paediatric population without major bleeding complications.
فهرسة مساهمة: Keywords: Alteplase; Prosthetic mitral valve; Thrombosis
المشرفين على المادة: EC 3.4.21.68 (Tissue Plasminogen Activator)
0 (Fibrinolytic Agents)
تواريخ الأحداث: Date Created: 20220603 Date Completed: 20230525 Latest Revision: 20230525
رمز التحديث: 20240829
DOI: 10.1017/S1047951122001652
PMID: 35656568
قاعدة البيانات: MEDLINE
الوصف
تدمد:1467-1107
DOI:10.1017/S1047951122001652